• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cns Pharmaceuticals Inc (NQ: CNSP )

    0.1196 -0.0004 (-0.33%)
    Streaming Delayed Price Updated: 12:48 PM EDT, Oct 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Cns Pharmaceuticals Inc

    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    Jimmy Carter Survival Thanks to Novel Cancer Immunotherapy Treatment
    Via Investor Brand Network
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at the 24th Annual Biotech in Europe Forum
    Via Investor Brand Network
    CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum
    Via ACCESSWIRE
    WHO Review Says No Link Between Mobile Phones, Brain-Cancer Development
    Via Investor Brand Network
    CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement
    Via ACCESSWIRE
    CNS Pharmaceuticals to Participate in at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
    Via ACCESSWIRE
    CNS Pharmaceuticals to Participate in Virtual Investor CEO Connect Segment
    Via ACCESSWIRE
    CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results
    Via ACCESSWIRE
    CNS Pharmaceuticals to Participate in the Virtual Investor Closing Bell Series
    Via ACCESSWIRE
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Slated to Present at H.C. Wainwright 26th Annual Global Investment Conference
    Via Investor Brand Network
    CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    Via ACCESSWIRE
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Latest BioMedWire Podcast Episode
    Via Investor Brand Network
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
    Via Investor Brand Network
    Brain Cancer in Kids Could Soon Be Detected by 10-Minute Scan
    Via Investor Brand Network
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Upcoming Virtual Investor CEO Connect Segment
    Via Investor Brand Network
    Scientists Find Way to Boost Natural Killer Cells Targeting Pediatric Brain Cancer
    Via Investor Brand Network
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Publishes Q2 2024 Results
    Via Investor Brand Network
    Exposures Product Safety
    Study Uncovers How Brain Tumors Evolve During Treatment
    Via Investor Brand Network
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Inks Exclusive License in ‘Transformational’ Step to Treating GBM
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    CNS Pharmaceuticals Expands Pipeline with In-License of Late Stage, Novel Potential Blood Brain Barrier Permeable Abeotaxane for Treatment of Brain Malignancies
    Via ACCESSWIRE
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CMO to Present Poster at Upcoming SNO/ASCO CNS Cancer Conference
    Via Investor Brand Network
    CNS Pharmaceuticals Announces Acceptance of Abstract for Poster Presentation at the 2024 SNO/ASCO CNS Cancer Conference
    Via ACCESSWIRE
    Study Uncovers Ancient Egyptian Attempts to Surgically Remove Brain Cancer
    Via Investor Brand Network
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Exec to Present at Upcoming Virtual Investor Closing Bell Series
    Via Investor Brand Network
    Research Identifies How Glioblastoma Develops Resistance to Immunotherapy
    Via Investor Brand Network
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enters Securities Purchase Agreements Worth Estimated $1.98M
    Via Investor Brand Network
    CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement
    Via ACCESSWIRE
    TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Pricing of Registered Direct, Concurrent Private Placement
    Via Investor Brand Network
    CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement
    Via ACCESSWIRE
    BioMedNewsBreaks — CNS Pharmaceuticals Inc.(NASDAQ: CNSP) Enters in Purchase Agreements, Announces Pricing
    Via Investor Brand Network
    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.